These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 14182459)
21. [CHANGES IN FIBRINOLYSIS AND BLOOD COAGULATION IN THROMBOLYTIC TREATMENT WITH STREPTOKINASE]. DONNER L; KRCILEK A Cas Lek Cesk; 1965 Jun; 104():641-5. PubMed ID: 14321919 [No Abstract] [Full Text] [Related]
22. THE DEVELOPMENT OF UROKINASE AS A THROMBOLYTIC AGENT. MAINTENANCE OF A SUSTAINED THROMBOLYTIC STATE IN MAN BY ITS INTRAVENOUS INFUSION. FLETCHER AP; ALKJAERSIG N; SHERRY S; GENTON E; HIRSH J; BACHMANN F J Lab Clin Med; 1965 May; 65():713-31. PubMed ID: 14281368 [No Abstract] [Full Text] [Related]
24. THE FIBRINOLYTIC SYSTEM IN HEALTH AND DISEASE. JOHNSON AJ; NEWMAN J Semin Hematol; 1964 Oct; 1():401-31. PubMed ID: 14225683 [No Abstract] [Full Text] [Related]
25. [ON THE MECHANISM OF ACTION OF FIBRINOLYTIC SUBSTANCES]. ROSOLLECK H Thromb Diath Haemorrh; 1963 Jul; 143():459-71. PubMed ID: 14081267 [No Abstract] [Full Text] [Related]
26. PLASMINOGEN AS A USEFUL PARAMETER IN THROMBOLYTIC THERAPY. DEVREKER R Sangre (Barc); 1964; 41():452-4. PubMed ID: 14248834 [No Abstract] [Full Text] [Related]
27. ON THE COMBINED ADMINISTRATION OF STREPTOKINASE AND PANCREATIC TRYPSIN INHIBITOR. VERSTRAETE M; VERMYLEN J; VERMYLEN C; DEVREKER RA Thromb Diath Haemorrh; 1964 Dec; 12():391-5. PubMed ID: 14254698 [No Abstract] [Full Text] [Related]
28. DIAGNOSIS OF FIBRINOLYTIC HEMORRHAGE. SHINAGAWA S; MAKI M; KIKUCHI I; NAGASAWA K; TAKANO A Tohoku J Exp Med; 1964 Jul; 83():183-95. PubMed ID: 14216989 [No Abstract] [Full Text] [Related]
29. [FIBRINOLYTIC THERAPY IN ACUTE MYOCARDIAL INFARCT. FIRST CLINICAL USE OF AN ACTIVATOR ADMINISTERED SUBLINGUALLY]. DONI A; BARTOLETTI L; BERNI G; DESTASIO A Clin Ter; 1964 Apr; 29():112-28. PubMed ID: 14161475 [No Abstract] [Full Text] [Related]
30. CURRENT APPRAISAL OF THROMBOLYTIC THERAPY. A CRITICAL REVIEW. LIEBERMAN J Calif Med; 1963 Nov; 99(5):301-7. PubMed ID: 14081772 [TBL] [Abstract][Full Text] [Related]
31. ORAL ADMINISTRATION OF A FIBRINOLYSIN IN VASCULAR INFLAMMATION AND OCCLUSION. VARGA LK; MITCHELL JP; MCGAVACK TH Nebr State Med J; 1964 Feb; 49():53-60. PubMed ID: 14117291 [No Abstract] [Full Text] [Related]
32. PRESENT STATUS OF THROMBOLYTIC THERAPY. JOHNSON AJ Am Heart J; 1964 Mar; 67():418-20. PubMed ID: 14129234 [No Abstract] [Full Text] [Related]
33. THROMBOANGIITIS OBLITERANS: WITH SPECIAL REFERENCE TO COAGULATION AND CLOT LYSIS. ENDE N Vasc Dis; 1964 Mar; 1():83-8. PubMed ID: 14186546 [No Abstract] [Full Text] [Related]
34. ACTIVATION OF THE FIBRINOLYTIC SYSTEM IN HUMAN BLOOD BY STREPTOKINASE AND CHANGES IN THIS SYSTEM AND IN THE EUGLOBULIN CLOT LYSIS TIME IN RELATION TO AGE AND SEX. KONTTINEN YP Scand J Clin Lab Invest; 1965; 17():SUPPL 82:1-111. PubMed ID: 14320094 [No Abstract] [Full Text] [Related]
36. [Thrombolytic therapy of cases of gynecological and obstetrical thrombosis]. FORGACS J; NEMETH L; ELEK E Orv Hetil; 1962 May; 103():921-5. PubMed ID: 13894054 [No Abstract] [Full Text] [Related]
37. The effectiveness of activators in clot lysis, with special reference to fibrinolytic therapy. A new method for determination of preformed clot lysis. BLIX S Acta Med Scand Suppl; 1962; 386():1-24. PubMed ID: 13971658 [No Abstract] [Full Text] [Related]
38. Fibrinolytic therapy of coronary thrombosis. Controlled trial of 75 cases. DEWAR HA; STEPHENSON P; HORLER AR; CASSELLS-SMITH AJ; ELLIS PA Br Med J; 1963 Apr; 1(5335):915-20. PubMed ID: 14027424 [No Abstract] [Full Text] [Related]
39. [APROPOS OF THROMBOLYTIC THERAPY]. DONNER L Cas Lek Cesk; 1964 Jan; 103():102-7. PubMed ID: 14129510 [No Abstract] [Full Text] [Related]